Opioids Analgesics Flashcards

1
Q

Describe the 3 different forms of analgesia

A

Local anaesthetics; analgesia close to the source of the pain

Central analgesia; analgesia through central/ spinal sites

GA; loss of consciousness +/- analgesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are the majority of opioid analgesics metabolised?

A

CYP enzymes p450 metabolic enzymes) in phase 1 of metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which opioid stands out in terms of metabolism?

A

Morphine; not metabolised by CYP in phase 1
Alternatively; morphine is metabolised in phase 2 via glucuronidation (kidney) via UGT2B7
This property of a lack of interaction with p450 (liver) enzymes makes it a useful drug as it is unlikely to interact with other drug metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the impact of CYP2D6 polymorphisms in opioid metabolism

A
Prone to polymorphisms e.g. ultra rapid metabolisers (strong analgesia and possible overdose; 1-2%) 
Extensive metabolisers (88%) 
Intermediate metabolises (8%) and poor metabolizers (8% - poor analgesia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Are codeine and hydrocodone pharmacologically active as its inert state?

A

No; metabolised by CYP2D6 to morphine where there is binding to opioid receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the impact of age on the prescribing of opioids

A

In general, older patients tend to have a reduced clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the effect of sex on the prescribing of opioids

A

Majority have no effects between sexes except;

Oxycodone; concentrations around 25% higher in women than men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the impact of ethnicity on the prescribing of opioids

A

Chinese patients tend to have a higher clearance of morphine (influence with enzymes involved with glucoronidation)

CYP2D6 allele variants may alter metabolism of codeine and hydrocodone; more common in Asian or African descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the impact of hepatic impairment on opioid prescribing

A

Dose adjustment recommended with morphine, codeine, oxycodone, methadone, hydromorphone

Oxycodone CI in hepatic impairment

Hydrocodone and codeine are often administered in combo with paracetamol; monitor LFTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the impact of renal impairment on opioid prescribing

A

Dose adjustment recommended for all

Caution with morphine (renally excreted)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the impact of substrates, inhibitors and inducers of p450 on the metabolism of opiates

A

Substrates such as statins, BZD, SSRIs and psych drugs also require p450 to be metabolised which therefore individuals who are taking these drugs should be treated with some opioids cautiously as the other drugs may be competing for metabolism

Inhibitors such as chemo agents, anti-fungal, antiretroviral drugs - these drugs bind to p450 and inhibit the enzyme action. Enhanced levels of opioids

Inducers such as statins and anticonvulsant agents act to increase the expression of p450; reduced circulating level of opioids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the 3 opioid receptors

A

MOPr (mu)
DOPr (delta)
KOPr (kappa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is alternative splicing?

A

Multiple different forms of mRNA can be produced from one single gene via splicing of exons and introns splicing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the interest with mu opioid receptor alternative splicing?

A

Alternative exons can be included in the mRNA
This can give rise to different types of mRNA in different cells
This results in the receptors having different functional properties
Variability between mu receptors in different brain regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Can opioid receptors comibine?

A

Yes; wealth of evidence to show that mu and delta receptors can combine to form heterooligomers/ dimers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the basic pharmacology of mu receptors

A

Gene; OPRM1
Selective agonist; DAMGO
G protein; Gi/o
Effectors; decreased adenylyl cyclase, increased potassium, decreased calcium
Numerous alternative splicing variants reported
Polymorphisms; 118 A-G; decreases morphine and alfentanil effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the basic pharmacology of delta receptors

A

Gene; OPRD1
Selective agonist; DPDPE
G protein; Gi/o
Effectors; decreased adenylyl cyclase, increased potassium, decreased calcium
Alternative splicing >1 likely
Polymorphisms; several, involved in naltrexone response in alcoholics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the basic pharmacology of kappa receptors

A

Gene; OPRK1
Selective agonist; U50
G protein; Gi/o
Effectors; decreased adenylyl cyclase, increased potassium, decreased calcium
Alternative splicing >1
Polymorphisms involved in naltrexone response in alcoholics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the basic pharmacology of nocicpetin receptors

A

Gene; ORL1
Selective agonist; nociceptin
G protein; Gi/o
Effectors; decreased adenylyl cyclase, increased K+, decreased Ca2+
3 alternative splicing variants reported
Polymorphisms involved with opioid addiction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How can muR polymorphisms affect opioid analgesia?

A

APRM1 A11G gene variant can decrease morphine’s analgesic responses post op
Carriers of G-allele observed to exhibit higher opioid analgesic requirements
Strongest in Asian patients, morphine users and those receiving surgery to a viscus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Where are opioid receptors expressed in the pain pathways?

A

Throughout;
Expressed in the primary afferent nociceptors, particularly are presynaptic terminal (to inhibit sub P and glutamate release to prevent excitation of DH neurons)
Thalamus
Cortex

Also involved with descending inhibitory control of pain pathway (disinhibit the neurons in PAG to allow for descending inhibitory influences in pain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What creates the central pore of a voltage activated calcium channel?

A

Alpha 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What subunits support and modify the actions of the calcium subunit?

A

Alpha 2
Delta
Beta - influences inactivation and voltage dependent activation
Gamma

Alpha 1 = pore conducting, contains pore loops which give selectivity to calcium ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Are there different types of voltage activated calcium channels?

A

Yes

Not all are inhibited by opioid binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe VA Ca2+ channels Cav 1.1-1.4

A

CaV 1.1-1.4; all sensitive to dihydropyridine (specific antagonist) = L type calcium channel (channel supports currents that are long lasting and therefore show less inactivation)

Excitation-contraction coupling of cardiac myocytes
Hormone release; regulates transcription, synaptic regulation, nT release from sensory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Describe VA Ca2+ channels Cav 3.1-3.3

A

No specific antagonist
T type channel; transient, inactivate more rapidly then L type

Pacemaker cells; repetitive firing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe VA Ca2+ channel Cav 2.3

A

R type; resistant to inactivation
Selective antagonist; SNX-482
Dendritic calcium transients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe VA Ca2+ channel CaV 2.2

A

N current; nerve terminal
Found on nerve cell terminals and dendrites
Controls nT release; dendritic Ca2+ transients; hormone release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Describe Va Ca2+ channel CaV 2.1

A

P/Q current; purkinje cells of cerebellum with a specific splice variant
nT release, dendritic calcium transients, hormonal release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Which calcium channels are most relevant to opioids?

A

CaV 2.1 and 2.2
Located at nerve terminals where they can affect nT release
These can be inhibited by opioid binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Describe the different types of calcium channels on their influence of neurons

A

L-type; cell soma, Influences gene expression

T-type; participate in rising phase of action potential as it travels through axon hillock

N and P/Q type; presynaptic where they control calcium entry into synaptic terminal; instrumental on vesicle docking and nT release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is the impact of mu opioid receptor coupling to calcium channels via whole cell patch clamp recording?

A

Beta gamma subunit of G protein binds to calcium channel to exert its effects - inactivation

Presence of DAMGO there is an inhibition of part of the voltage activated calcium current (but not completely) - therefore suggests that there are other types of calcium channel types in the cell (not just N, P/Q) such as resistant L or T type calcium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Describe tolerance to opioids

A

Adaptation that occurs in the neurons that respond to neurons leading to reduced sensitivity and reduced analgesia

However, this is not a reduction in efficacy but instead a reduction in potency - higher doses are required to create the same level of analgesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What other aspect of opioid analgesic side effect can tolerance create?

A

Opioid induced hyperalgesia

Pain initially goes down on exposure to morphine, after prolonged exposure there is a paradoxical recovery of pain perception, but individuals can become hyperalgesic

This is due to tolerance to endogenous opioid production - lack of potency of exogenous analgesics but also a decline of innate ability to resist pain via endogenous opioid signalling mechanisms

Stimuli that previously doesn’t cause pain becomes painful (allodynia) resulting in a hypersensitivity to pain (hyperalgesia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Describe the main side effects of opioid analgesia

A
Reward = addiction 
Resp depression 
Immunosuppression 
Constipation 
Hyperalgesia
Tolerance/ dependence
36
Q

Describe the 4 mechanisms that underlie tolerance

A

Receptor tolerance: decreased surface receptor, decreased receptor coupling, decreased receptor protein, decreased receptor RNA

Cell tolerance and withdrawal: initially decreased cAMP, with then an adaptation. Therefore on removal of the opioid, there is an unmasked hypertrophy of cAMP

System tolerance and withdrawal: feedback circuits adapt

Synaptic plasticity in tolerance and withdrawal: well established at GABAergic synapses. increased AMPAR insertion; increased LTP to drug seeking behaviour

37
Q

Describe potential targets for peripheral nociception inhibition (novel analgesics)

A

Selective Nav and Kv ligands
Cav, TRP and P2X antagonists
Biased GPCR signalling
GPRC dimers

38
Q

Describe potential targets for central (DH) targets for novel analgesics

A
Opioid receptors 
Cannabinoid receptors 
mGluRs 
GABA
AMPA/ NMDA 
Microglial cells
Astrocytes
39
Q

Is it easy to demonstrate opioid tolerance in the lab?

A

Yes; tail withdrawal assay

10mg/kg a day; shows tolerance by day 4

40
Q

Does morphine analgesia require mu receptors?

A

Yes; MOR +/- mice causes a rightward shift in the dose response to morphine
MOR -/- mice show no analgesic affects in response to morphine analgesia

41
Q

What do mu receptors mediate in the effects of opioid analgesia?

A
Analgesia
Reward
Resp depression 
Immunosuppression 
Constipation 
Tolerance, withdrawal and dependence
42
Q

What was the effect of specific k/o of mu receptors in nociceptors but not the microglia?

A

The effect of morphine tolerance was abolished with no disruption of analgesia

Peripheral mu opioid receptor expression on nociceptors is required for full analgesic tolerance

Interesting research to lead to development of novel analgesics which antagonist the peripherally located mu opioid receptors - hypothetically, this would decrease tolerance with no effects on central analgesic effects

43
Q

How does the mu receptor activation cause tolerance?

A

Primarily due to beta arrestin protein 2 (bind to GPCRs)

44
Q

What is the action of barr2 to result in opioid receptor tolerance

A

B-Arr2 will endocytose mu receptors via formation of clathrin coated pits. This allows for recycling of the receptor to be reinserted to the membrane without the agonist present.

Additionally brings kinases such as MAPK, Src, Akt to the receptor to phosphorylate downstream effectors

Can result in lysosomal degradation of the mu receptor

45
Q

What are the effects on opioids in b-arr2 k/o mice?

A
Lack of tolerance development 
Decreased resp depression 
Decreased constipation 
Increased reward 
Increased basal analgesia mediated by constituently active MOPrs
46
Q

What happens in +/- MOPs in terms of tolerance to morphine analgesia?

A

Shift in dose response to analgesia; show a basal level of tolerance
Apply morphine daily; much more profound tolerance to WT

No. of Mu opioid receptors is critical to the rate of analgesic tolerance develops

47
Q

Are the delta receptors required for tolerance to morphine analgesia?

A

Delta doesn’t play much of a role in morphine analgesia (-/- DOP show similar dose dependency to morphine at WT)

Morphine tolerance is greatly diminished in -/- and +/- mice

DOP participates in tolerance

48
Q

How can delta receptors influence tolerance of mu receptors?

A

Formation of heterodimers

Mu and delta receptors can combine and influence each others properties

This heterodimer has distinctive properties

This can occur in the SC and DH neurons

49
Q

Is there a link between DOPrs and b-arr2?

A

DOPr recruits B-arr2 to MOPrs

These heterodimers recruit b-arr2 in the absence of an agonist

TOLERANCE

50
Q

Do DOPs MOPrs dimers modulate analgesia?

A

Delta -/- and +/- show resistance to the development of tolerance

Antagonism of DOPs reduced morphine tolerance

Bivalent drugs with MOP and DOP antagonist may be advantageous

The bivalent opioid MDAN-21 analgesic causes little tolerance and dependence in mice

51
Q

Does morphine internalize MOP receptors?

A

No; after 30 mins of exposure, morphine fails to cause endocytosis of mu opioid receptor

This analgesia shows tolerance

Mu opioid receptors become phosphorylated, with increased expression of B-arr2 = densitization

52
Q

Does DAMGO internalize MOP receptors?

A

Yes; rapid endocytosis of mu opioid receptors

This analgesic mechanism does not cause tolerance

Therefore this result is the complete opposite of what is expected (you would associate tolerance with an internalization of mu opioid receptors)

53
Q

What is the RAVE hypothesis?

A

Receptor Activation Versus Endocytosis – endocytosis resensitized receptors

Agonists that activate receptors without inducing endocytosis cause more tolerance because endocytosis allows for re-sensitization of desensitized receptors

This was proposed to explain greater tolerance induced by on-internalizing agonist morphine

54
Q

What is the proposition to explain why different agonists at mu cause different side effects?

A

Agonist mediated phosphorylation after its bound the agonist

In order to recruit b-arr the mu receptor must be phosphorylated at the C-terminal. This phosphorylation occurs at theoronine and seronine residues

55
Q

Describe the barcode hypothesis

A

Biased agonists bind to opioid receptors

If balanced; agonists activate a range of different types of kinases to lead to G protein signalling and B-arr2 recruitment

However; the agonists can be biased

G-protein biased ligand (endogenous opiate peptides) leads to activation of GRK2/3 –> recruitment of B-arr2 which allows for internalization of receptor (no tolerance)

B-arr biased ligand (alkaloids e.g. morphine) leads to activation of GRK5/6 –> activation of B-arr2 in a conformation that results in downstream signalling and NO internalization of mu (TOLERANCE)

56
Q

Describe the ability of DAMGO, morphine and PZM21 to activate G1 and to recruit B-rr2

A

DAMOG; highest levels of G1 activation. Highest levels of B-arr2 recruitment

Morphine; Intermediate levels of G1 activation, much lower B-rr2 recruitment

PZM21; similar G activation to morphine, no b-arr2 recruitment

57
Q

What is PZM21

A

Functionally selective mu opioids receptor which produced mu opioid receptor mediated G1 signalling with a similar potency and efficacy as morphine, but much less/no B-arr2 recruitment

Biased novel mu receptor agonist

58
Q

Describe the difference between the experimental paradigms; hotplate analgesia and tail-flick analgesia

A

Hotplate analgesia; effective response. Measures the licking of paw after exposure to a hot plate (increased analgesia, reduced licking)

Tail flick is a reflexive response

59
Q

Describe the impact of PZM-21 to hotplate analgesia and tail flick analgesia

A

Hotplate analgesia - very similar to morphine

Tail-flick analgesia - very limited effect

Can therefore postulate that PZM-21 has its effects out-with the CNS and modulates the behaviour towards pain

60
Q

Describe the impact of PZM-21 on constipation and resp depression (linked to b-arr2 recruitment)

A

PZM-21 causes less constipation than morphine

PZM-21 causes much less resp depression (resp frequency) than morphine

This is relevant to the danger of opioids

However, further studies have demonstrated that it may act more like a partial agonist and puts into question the decreased resp depression assoc with PZM-21

61
Q

Is there a link between G protein activation and side effect profiles of opioids

A

Low intrinsic efficacy for Gi can explain an improved side effect profile

Likely partial agonists

Increased therapeutic window as the intrinsic efficacy goes down (inverse correlation)

Improved therapeutic drugs are less to do with bias but more to do with G protein efficacy

62
Q

Describe the mechanisms of morphine tolerance

A

G protein signal leads to phosphorylation of opioids receptor
B-arr2 recruitment and arrestin binding leading to endocytosis

63
Q

What is the cell response of GTP and b-arr2 in opioid binding

A

Decreased cAMP
Decreased calcium
Increased potassium
Increased MAPK, Scr and Akt

64
Q

Describe the role of Scr in morphine tolerance

A

Regulation of the constitutive activity and recycling of mu opioid receptors in the DRG

65
Q

Describe the impact of dasatinib (Src inhibitor) on morphine

A

Prevents morphine tolerance in inflammatory hyperalgesia

Tail withdrawal latency; again prevents morphine tolerance quite significantly

66
Q

Does dasatinib change the dose dependent relationship to morphine?

A

No; no change in morphine or basal tail withdrawal latencies

**Inhibition of Src Kinase can prevent morphine tolerance

67
Q

Can dasatinib reverse morphine tolerance?

A

Yes; morphine alone for 3 days, after 3 days with dasatinib, there was reversal of morphine tolerance

68
Q

What has C-Src been implicated in?

A

Neuropathic and inflammatory pain

Phosphorylates NMRAR to enhance the response == hyperalgesia

Hub for NMDA receptor regulation

We know NMDA receptors are involved in pain due to the action of ketamine

NMDA receptors are responsible for the aspects of morphine evoked tolerance

69
Q

Describe some drugs which can improve opioid analgesia

A

Naloxone and methylnaltrexone (mu opioid antagonist)

Dasatinib (Scr)

Ketamine (NMDA)

Rapamycin (mTORC1)

70
Q

Describe the use of opioids in the perioperative period

A

Could complicate and hinder recovery

Impact on the need for prolonged opioid analgesia

71
Q

Describe the multimodal analgesia therapies utilized to reduce the reliance on opioids in the perioperative period

A

Simple analgesia; paracetamol, NSAIDs

Anti-neuropathic drugs and atypical analgesia; gabapentinoids, ketamine, magnesium, alpha 2 adrenergic agonists, steroids, IV lidocaine

Invasive techniques; nerve blocks with LA

72
Q

Describe the role of Nav1.7 mutation in the sensitivity of pain

A

Endogenous opioids contribute to insensitivity to pain in humans and mice lacking Na+ channel NaV1.7

Upregulation of endogenous opioid release from nociceptive peptides

73
Q

Is there dysregulation of pain in fibromyalgia at a molecular level?

A

Endogenous opioidogenic dysregulation
Reduction in regions in which opioid systems are found
Reduction in PET imaging analysis of mu opioid receptor expression

In some situations in which pain is enhanced; there is evidence for a dysfunctional endogenous opioid system

74
Q

Can acupuncture help with pain?

A

Yes; can stimulate endogenous opioid systems

75
Q

How can the placebo effects related to analgesics be explained?

A

Placebo effects are mediated by endogenous opioid activity on mu opioid receptors

76
Q

Describe the role of innate analgesia on inflammatory hyperalgesia

A

Inflammatory pain decreases even when the inflammation is still present

This is due to an upregulation of endogenous opioids

When naltrexone is administered, the inflammatory hyperalgesia returns. This suggests that there is endogenous opioid activity

Tissue injury produces muR constitutive activity that represses spinal nociceptive signalling for months

77
Q

How can the fragmented maternal care be quantified?

A

Dam number of sorties

Much more in restricted bedding paradigm

78
Q

What is the impact of ELA on sensitivity to pain?

A

CFA to evoke inflammatory sensitivity

ELA mice show statistically significant enhancement of mechanical withdrawal threshold. Prior to application of the adjuvant, there is an upregulation of the analgesic response in mice

When exposed to adjuvant; both control and ELA mice show heightened mechanical sensitivity

ELA mice tend to be more resistant to acute pain.

However, ELA mice show increased tolerance to upregulated mu constitutive opioid receptor function. Greater degree of chronic pain in ELA mice

79
Q

What is the impact of ELA on response to noxious heat?

A

Enhanced resilience to noxious heat in the acute setting (basal tail latency)

However, the tail withdrawal latency declines, similar to inflammatory hyperalgesia paradigm

Increased tolerance in ELA

80
Q

Is there differences in ELA mice response to morphine?

A

Dose response relationship to morphine is shifted to the right for ELA mice.

Consistent with increased tolerance; shift of the dose response relation ship to the right

Tolerance develops rapidly and to a much greater extent

Upregulation of endogenous opioid signalling which then primes the receptors to tolerance when exposed to exogenous alkaloid molecules such as morphine

81
Q

What is epigenetics?

A

Study of heritable phenotype changes that do not involve alteration in the DNA sequence

External modifications to DNA that turns genes on or off with no modifications of DNA sequence, but instead how these cells read genes.

Epigenetics alter the physical structure of DNA; not the molecular sequence

82
Q

How does ELA confer epigenetic changes?

A

ELA gives rise to altered neural signals which influence regulatory genes within the cell - influences acetylation and regulation of pain, and opioid receptors

Epigenetic markers control where and how much protein is made by a gene, effectively turning it on or off, thereby shaping how brains and bodies develop

83
Q

Is there a change in MOR gene expression in ELA mice?

A

Thalamus; reduction in mu opioid receptor expression (esp female mice - pain sensitivity between males and females varies)

84
Q

Is there a change in DOR gene expression in ELA mice?

A

Upregulation of delta expression in the spinal cord; stat significantly in male and female mice

This upregulation of DOR in the spinal cord gives rise to increased mu-delta heterodimers which show a greater tendency to tolerance development (ability to pre-recruit b-arr2)

Altered pain signalling = enhanced tolerance

85
Q

Does exposure to ELA increase risk for chronic pain later in life?

A

Yes; children and adolescents with ACEs had an increased risk for chronic pain, and this association increased in a dose-dependent fashion (strongest associations included financial instability, living with a mentally ill adult or having experienced race discrimination)